These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37390030)

  • 1. Barriers and facilitators to prescribing medicinal cannabis in New Zealand.
    Withanarachchie V; Rychert M; Wilkins C
    J Prim Health Care; 2023 Jun; 15(2):135-146. PubMed ID: 37390030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cannabis clinics in the health system: a qualitative study of physicians' views in New Zealand.
    Withanarachchie V; Rychert M; Wilkins C
    BMC Health Serv Res; 2023 Jan; 23(1):10. PubMed ID: 36600251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the medical cannabis prescribing behaviours of New Zealand physicians.
    Manoharan R; Kemper J; Young J
    Drug Alcohol Rev; 2022 Sep; 41(6):1355-1366. PubMed ID: 35604868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'The wild west of medicine': A qualitative investigation of the factors influencing Australian health-care practitioners' delivery of medicinal cannabis.
    Dobson O; Barber M; Graham M; Carter A; Savic M
    Drug Alcohol Rev; 2024 Jul; 43(5):1280-1293. PubMed ID: 38630896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of the Medicinal Cannabis Scheme in New Zealand: six emerging trends.
    Rychert M; Wilkins C
    N Z Med J; 2024 Oct; 137(1604):73-86. PubMed ID: 39418607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicians' experiences, attitudes, and beliefs towards medical cannabis: a systematic literature review.
    Rønne ST; Rosenbæk F; Pedersen LB; Waldorff FB; Nielsen JB; Riisgaard H; Søndergaard J
    BMC Fam Pract; 2021 Oct; 22(1):212. PubMed ID: 34674661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical cannabis: knowledge and expectations in a cohort of North Island New Zealand general practitioners.
    Oldfield K; Braithwaite I; Beasley R; Eathorne A; Newton-Howes G; Semprini A
    N Z Med J; 2020 Jan; 133(1508):12-28. PubMed ID: 31945040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of medicinal cannabis users' willingness to utilise a new prescription Medicinal Cannabis Scheme in New Zealand.
    Rychert M; Parker K; Wilkins C; Graydon-Guy T
    N Z Med J; 2021 Apr; 134(1534):66-75. PubMed ID: 33927439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge and attitudes of Australian general practitioners towards medicinal cannabis: a cross-sectional survey.
    Karanges EA; Suraev A; Elias N; Manocha R; McGregor IS
    BMJ Open; 2018 Jul; 8(7):e022101. PubMed ID: 29970456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Rise and Rise of Medicinal Cannabis, What Now? Medicinal Cannabis Prescribing in Australia 2017-2022.
    Hallinan CM; Bonomo YA
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences, patient interactions and knowledge regarding the use of cannabis as a medicine in a cohort of New Zealand doctors in an oncology setting.
    Oldfield K; Eathorne A; Tewhaiti-Smith J; Beasley R; Semprini A; Braithwaite I
    Postgrad Med J; 2022 Jan; 98(1155):35-42. PubMed ID: 33218966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of medicinal cannabis in Australia: innovation or upheaval? Perspectives from physicians as key informants, a qualitative analysis.
    Hallinan CM; Gunn JM; Bonomo YA
    BMJ Open; 2021 Oct; 11(10):e054044. PubMed ID: 34686558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring medicinal use of cannabis in a time of policy change in New Zealand.
    Rychert M; Wilkins C; Parker K; Graydon-Guy T
    N Z Med J; 2020 May; 133(1515):54-69. PubMed ID: 32438377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge, experiences, and attitudes of Australian General Practitioners towards medicinal cannabis: a 2021-2022 survey.
    Bawa Z; McCartney D; Manocha R; McGregor IS
    BMC Prim Care; 2022 Dec; 23(1):330. PubMed ID: 36529730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicinal Cannabis Guidance and Resources for Health Professionals to Inform Clinical Decision Making.
    Graham M; Renaud E; Lucas CJ; Schneider J; Martin JH
    Clin Ther; 2023 Jun; 45(6):527-534. PubMed ID: 37414503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Medicinal Cannabis in Clinical Therapy: Pharmacists' Perspectives.
    Isaac S; Saini B; Chaar BB
    PLoS One; 2016; 11(5):e0155113. PubMed ID: 27171490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis-based medicinal products and the role of the doctor: should we be cautious or cautiously optimistic?
    Braithwaite I; Newton-Howes G; Oldfield K; Semprini A
    N Z Med J; 2019 Aug; 132(1500):82-88. PubMed ID: 31415502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicinal cannabis for the treatment of anxiety disorders.
    Berger M; Amminger GP; McGregor IS
    Aust J Gen Pract; 2022 Aug; 51(8):586-592. PubMed ID: 35908759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis Use for Endometriosis: Clinical and Legal Challenges in Australia and New Zealand.
    Sinclair J; Toufaili Y; Gock S; Pegorer AG; Wattle J; Franke M; Alzwayid MAKM; Abbott J; Pate DW; Sarris J; Armour M
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):464-472. PubMed ID: 34978929
    [No Abstract]   [Full Text] [Related]  

  • 20. Medicinal cannabis use in palliative care.
    Herbert A; Hardy J
    Aust J Gen Pract; 2021 Jun; 50(6):363-368. PubMed ID: 34059839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.